Header Logo

Connection

JASON HOU to Certolizumab Pegol

Back to Details
This is a "connection" page, showing publications JASON HOU has written about Certolizumab Pegol.
JASON HOU
Connection Strength
0.136
Certolizumab Pegol
  1. Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists. Inflamm Bowel Dis. 2017 02; 23(2):254-260.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.